DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis

FRA:DMP • DE000A2GS5D8

36.8 EUR
-0.1 (-0.27%)
Last: Feb 16, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

DMP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 52 industry peers in the Pharmaceuticals industry. DMP has only an average score on both its financial health and profitability. DMP has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year DMP was profitable.
  • In the past year DMP had a positive cash flow from operations.
  • Each year in the past 5 years DMP has been profitable.
  • DMP had a positive operating cash flow in each of the past 5 years.
DMP.DE Yearly Net Income VS EBIT VS OCF VS FCFDMP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.48%, DMP is in line with its industry, outperforming 48.08% of the companies in the same industry.
  • With a Return On Equity value of 17.87%, DMP perfoms like the industry average, outperforming 57.69% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 7.26%, DMP is in line with its industry, outperforming 44.23% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DMP is below the industry average of 14.38%.
Industry RankSector Rank
ROA 5.48%
ROE 17.87%
ROIC 7.26%
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
DMP.DE Yearly ROA, ROE, ROICDMP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • The Profit Margin of DMP (10.00%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of DMP has declined.
  • With a Operating Margin value of 18.70%, DMP perfoms like the industry average, outperforming 48.08% of the companies in the same industry.
  • DMP's Operating Margin has improved in the last couple of years.
  • DMP has a worse Gross Margin (66.57%) than 61.54% of its industry peers.
  • DMP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.7%
PM (TTM) 10%
GM 66.57%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
DMP.DE Yearly Profit, Operating, Gross MarginsDMP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • DMP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, DMP has about the same amount of shares outstanding.
  • The number of shares outstanding for DMP remains at a similar level compared to 5 years ago.
  • Compared to 1 year ago, DMP has a worse debt to assets ratio.
DMP.DE Yearly Shares OutstandingDMP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
DMP.DE Yearly Total Debt VS Total AssetsDMP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.22 indicates that DMP is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of DMP (2.22) is comparable to the rest of the industry.
  • DMP has a debt to FCF ratio of 6.15. This is a slightly negative value and a sign of low solvency as DMP would need 6.15 years to pay back of all of its debts.
  • DMP has a Debt to FCF ratio of 6.15. This is comparable to the rest of the industry: DMP outperforms 50.00% of its industry peers.
  • DMP has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
  • DMP's Debt to Equity ratio of 1.44 is on the low side compared to the rest of the industry. DMP is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 6.15
Altman-Z 2.22
ROIC/WACC1.07
WACC6.76%
DMP.DE Yearly LT Debt VS Equity VS FCFDMP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • DMP has a Current Ratio of 2.20. This indicates that DMP is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.20, DMP is in the better half of the industry, outperforming 71.15% of the companies in the same industry.
  • DMP has a Quick Ratio of 1.04. This is a normal value and indicates that DMP is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.04, DMP is doing good in the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.04
DMP.DE Yearly Current Assets VS Current LiabilitesDMP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • DMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.01%, which is quite impressive.
  • DMP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.07% yearly.
  • Looking at the last year, DMP shows a small growth in Revenue. The Revenue has grown by 0.11% in the last year.
  • Measured over the past years, DMP shows a quite strong growth in Revenue. The Revenue has been growing by 11.00% on average per year.
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%

3.2 Future

  • Based on estimates for the next years, DMP will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.68% on average per year.
  • Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 2.40% on average per year.
EPS Next Y11.31%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
EPS Next 5Y14.68%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y2.4%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DMP.DE Yearly Revenue VS EstimatesDMP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
DMP.DE Yearly EPS VS EstimatesDMP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.12, which indicates a rather expensive current valuation of DMP.
  • Based on the Price/Earnings ratio, DMP is valued a bit cheaper than the industry average as 67.31% of the companies are valued more expensively.
  • DMP is valuated rather cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 14.62, DMP is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 73.08% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, DMP is valued a bit cheaper.
Industry RankSector Rank
PE 17.12
Fwd PE 14.62
DMP.DE Price Earnings VS Forward Price EarningsDMP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 78.85% of the companies listed in the same industry.
  • 84.62% of the companies in the same industry are more expensive than DMP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.05
EV/EBITDA 9.41
DMP.DE Per share dataDMP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.51
PEG (5Y)2.12
EPS Next 2Y10.93%
EPS Next 3Y10.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • DMP has a Yearly Dividend Yield of 2.44%.
  • DMP's Dividend Yield is a higher than the industry average which is at 1.89.
  • Compared to an average S&P500 Dividend Yield of 1.82, DMP pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.44%

5.2 History

  • The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
DMP.DE Yearly Dividends per shareDMP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • 41.76% of the earnings are spent on dividend by DMP. This is a bit on the high side, but may be sustainable.
  • DMP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP41.76%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
DMP.DE Yearly Income VS Free CF VS DividendDMP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DMP.DE Dividend Payout.DMP.DE Dividend Payout, showing the Payout Ratio.DMP.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DERMAPHARM HOLDING SE

FRA:DMP (2/16/2026, 7:00:00 PM)

36.8

-0.1 (-0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-13
Earnings (Next)03-17
Inst Owners11.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.98B
Revenue(TTM)1.16B
Net Income(TTM)116.03M
Analysts78.18
Price Target42.84 (16.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.44%
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.14%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
Industry RankSector Rank
PE 17.12
Fwd PE 14.62
P/S 1.71
P/FCF 12.05
P/OCF 9.59
P/B 3.05
P/tB N/A
EV/EBITDA 9.41
EPS(TTM)2.15
EY5.84%
EPS(NY)2.52
Fwd EY6.84%
FCF(TTM)3.05
FCFY8.3%
OCF(TTM)3.84
OCFY10.42%
SpS21.55
BVpS12.06
TBVpS-7.73
PEG (NY)1.51
PEG (5Y)2.12
Graham Number24.15
Profitability
Industry RankSector Rank
ROA 5.48%
ROE 17.87%
ROCE 11.89%
ROIC 7.26%
ROICexc 7.91%
ROICexgc 21.74%
OM 18.7%
PM (TTM) 10%
GM 66.57%
FCFM 14.17%
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 6.15
Debt/EBITDA 3.09
Cap/Depr 49.31%
Cap/Sales 3.63%
Interest Coverage 4.01
Cash Conversion 68.3%
Profit Quality 141.71%
Current Ratio 2.2
Quick Ratio 1.04
Altman-Z 2.22
F-Score7
WACC6.76%
ROIC/WACC1.07
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
EPS Next Y11.31%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
EPS Next 5Y14.68%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y2.4%
EBIT growth 1Y5.29%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.22%
EBIT Next 3Y19.63%
EBIT Next 5Y7.01%
FCF growth 1Y-31.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-25.65%
OCF growth 3Y-7%
OCF growth 5Y14.89%

DERMAPHARM HOLDING SE / DMP.DE FAQ

What is the fundamental rating for DMP stock?

ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.


Can you provide the valuation status for DERMAPHARM HOLDING SE?

ChartMill assigns a valuation rating of 5 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.


How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?

DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of DERMAPHARM HOLDING SE (DMP.DE) stock?

The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 17.12 and the Price/Book (PB) ratio is 3.05.


Can you provide the expected EPS growth for DMP stock?

The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 11.31% in the next year.